LALPATHLAB
Invest with MTF
Invest Now
Invest in Dr. Lal Pathlabs with 3.53X leverage
Performance
- Low
- ₹2,846
- High
- ₹2,954
- 52 Week Low
- ₹2,294
- 52 Week High
- ₹3,540
- Open Price₹2,914
- Previous Close₹2,915
- Volume168,289
Investment Returns
- Over 1 Month -7.18%
- Over 3 Month -9.5%
- Over 6 Month -0.01%
- Over 1 Year -8.37%
Smart Investing Starts Here Start SIP with Dr. Lal Pathlabs for Steady Growth!
Dr. Lal Pathlabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 45.1
- PEG Ratio
- 1.4
- Market Cap Cr
- 24,080
- P/B Ratio
- Average True Range
- 84.23
- EPS
- 63.78
- Dividend Yield
- 0.9
- MACD Signal
- -32.07
- RSI
- 30.74
- MFI
- 12.46
Dr. Lal Pathlabs Financials
Dr. Lal Pathlabs Technicals
EMA & SMA
Current Price
₹2,874.40
-40.1
(-1.38%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹3,044.57
- 50 Day
- ₹3,099.67
- 100 Day
- ₹3,094.22
- 200 Day
- ₹3,030.42
Resistance and Support
2891.57
- R3 3,044.23
- R2 2,999.07
- R1 2,936.73
- S1 2,829.23
- S2 2,784.07
- S3 2,721.73
Dr. Lal Pathlabs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-10-31 | Qtr Results, Int.Dividend & Bonus issue | |
| 2025-07-31 | Quarterly Results, Dividend & Others | To consider other business matters. per share (60%) Second Interim Dividend |
| 2025-04-25 | Audited Results & Final Dividend | |
| 2025-01-30 | Quarterly Results, Dividend & Others | To consider other business matters. per share (60%) Second Interim Dividend |
| 2024-10-23 | Quarterly Results & Interim Dividend |
Dr. Lal Pathlabs F&O
About Dr. Lal Pathlabs
- NSE Symbol
- LALPATHLAB
- BSE Symbol
- 539524
- ISIN
- INE600L01024
Similar Stocks to Dr. Lal Pathlabs
Dr. Lal Pathlabs FAQs
Dr. Lal Pathlabs share price is ₹2,874 As on 10 December, 2025 | 20:46
The Market Cap of Dr. Lal Pathlabs is ₹24080.4 Cr As on 10 December, 2025 | 20:46
The P/E ratio of Dr. Lal Pathlabs is 45.1 As on 10 December, 2025 | 20:46
The PB ratio of Dr. Lal Pathlabs is 11.1 As on 10 December, 2025 | 20:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.